featured
Time to Loss of Response Following Withdrawal of Ixekizumab in Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Acta Dermato-Venereologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis
Acta Derm Venereol 2022 Mar 15;102(xx)adv00672, K Papp, C Paul, CE Kleyn, YH Huang, TF Tsai, C Schuster, C El Baou, A Toth, E Riedl, U MrowietzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.